In-Vitro Lung Model Market Outlook Highlights The Next Major Growth Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
In-Vitro Lung Model Market Size, Value And Growth Trends Through 2030
The market for in-vitro lung models has seen substantial expansion over the last few years. Its value is projected to climb from $0.54 billion in 2025 to $0.65 billion in 2026, reflecting a compound annual growth rate (CAGR) of 21.0%. This past growth has been driven by factors such as the shortcomings of animal models in respiratory studies, the traditional reliance on two-dimensional lung cell cultures, a rise in research focused on respiratory diseases, an increase in academic investigations into lung biology, and the early integration of organoid-based research techniques.
The market for in-vitro lung models is projected to experience substantial expansion over the coming years. By 2030, its value is anticipated to reach $1.29 billion, reflecting a compound annual growth rate (CAGR) of 18.6%. This upward trajectory during the forecast period is driven by several key factors, including a growing need for predictive preclinical lung models, a heightened emphasis on minimizing animal testing, an expanding pipeline for respiratory drug development, increased funding for sophisticated in-vitro research tools, and a demand for lung disease models that more accurately mimic physiological conditions. Among the prominent trends shaping this period are the wider adoption of three-dimensional lung models in drug discovery, the increased utilization of lung-on-a-chip platforms for modeling diseases, a shift toward human-relevant in-vitro lung testing systems, the broader application of these models in toxicology and safety assessments, and their deeper integration into preclinical research workflows.
Download A Free Sample Report For Comprehensive Market Insights:
In-Vitro Lung Model Market Development Factors: Which Trends Are Supporting Demand?
The rising number of clinical studies is anticipated to drive growth in the in vitro lung model market moving forward. Clinical studies are research investigations designed to assess the safety, efficacy, and results of new medical treatments, drugs, or diagnostic tools in human subjects. This increase in clinical studies is fueled by expanding healthcare demands, a growing need for advanced therapeutic options, and the search for innovative approaches to address complex health issues. The in vitro lung model market facilitates clinical research by providing controlled environments that allow for drug testing, toxicity assessments, disease modeling, and the examination of lung-specific biological processes. As an example, in January 2024, ClinicalTrials.gov, a clinical trial registry based in the United States, reported that 477,230 clinical trials were registered worldwide by the end of 2023, up from 437,508 in 2022. Consequently, the surge in clinical studies is propelling the in vitro lung model market forward.
In-Vitro Lung Model Market Segment Landscape: Which Areas Lead Market Development?
The in-vitro lung model market covered in this report is segmented –
1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures
2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models
In-Vitro Lung Model Market Transformation Trends: Which Innovations Are Driving Change?
Leading players in the in vitro lung model industry are prioritizing the creation of advanced three-dimensional respiratory tissue constructs to boost physiological accuracy, refine predictive capabilities, and augment preclinical testing effectiveness. A 3D respiratory tissue construct is a laboratory-engineered, three-dimensional configuration cultivated from primary or dedicated respiratory cells under conditions that enable them to imitate the structure and operation of human airway tissues, including mucus secretion, ciliary action, and barrier function. As an example, in April 2023, MatTek Corporation, a biotechnology firm headquartered in the United States, launched EpiNasal, a 3D respiratory tissue construct derived from primary human nasal epithelial cells. This model reproduces functional characteristics of nasal epithelium, such as goblet cells, robust tight junctions, and beating cilia, offering scientists a relevant platform to assess the impact of medications, chemical substances, pathogens, and consumer goods on respiratory tissues.
In-Vitro Lung Model Market Industry Leaders And Market Competition
Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH
Access The Complete In-Vitro Lung Model Market Report:
In-Vitro Lung Model Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
